Syra Financial Statements From 2010 to 2026

SYRA Stock  USD 0.08  0  2.37%   
Syra Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Syra Health's valuation are provided below:
Gross Profit
2.2 M
Profit Margin
(0.17)
Market Capitalization
979 K
Enterprise Value Revenue
0.4951
Revenue
7.5 M
We have found one hundred twenty available fundamental trend indicators for Syra Health Corp, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Syra Health Corp current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Syra Health Total Revenue

5.64 Million

Check Syra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.1 K, Other Operating Expenses of 14.2 M or Total Operating Expenses of 6.5 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 0.98. Syra financial statements analysis is a perfect complement when working with Syra Health Valuation or Volatility modules.
  
Build AI portfolio with Syra Stock
Check out the analysis of Syra Health Correlation against competitors.

Syra Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.5 M4.2 M1.1 M
Slightly volatile
Short and Long Term Debt Total435.8 K519.9 K174.5 K
Slightly volatile
Other Current Liabilities160.4 K264.9 K70.4 K
Slightly volatile
Total Current Liabilities776.5 K705.6 K299 K
Slightly volatile
Cash2.9 M2.8 M674.1 K
Slightly volatile
Cash And Short Term Investments2.9 M2.8 M674.1 K
Slightly volatile
Common Stock Shares Outstanding7.2 M8.4 M6.4 M
Slightly volatile
Liabilities And Stockholders Equity2.5 M4.2 M1.1 M
Slightly volatile
Total Liabilities851.7 K920.9 K336.2 K
Slightly volatile
Short and Long Term Debt282.8 K175.8 K104.4 K
Slightly volatile
Total Current Assets2.2 M3.9 M942.3 K
Slightly volatile
Capital Stock11.8 K11.3 K3.3 K
Slightly volatile
Short Term Debt360.5 K304.6 K137.3 K
Slightly volatile
Common Stock11.8 K11.3 K3.3 K
Slightly volatile
Other Current Assets177.3 K318 K81 K
Slightly volatile
Other Stockholder Equity14.1 M13.4 MM
Slightly volatile
Other Assets1.2 K1.1 K198
Slightly volatile
Current Deferred Revenue13.3 K14.9 K16.3 K
Slightly volatile

Syra Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization39.1 K72.1 K47.1 K
Pretty Stable
Other Operating Expenses14.2 M13.5 M3.4 M
Slightly volatile
Total Operating Expenses6.5 M6.2 M1.5 M
Slightly volatile
Selling General Administrative3.4 M5.5 M1.5 M
Slightly volatile
Selling And Marketing ExpensesM3.8 M903.1 K
Slightly volatile
Total Revenue5.6 M9.2 MM
Slightly volatile
Gross Profit1.3 M1.9 M731.8 K
Slightly volatile
Cost Of Revenue4.4 M7.3 M2.3 M
Slightly volatile
Reconciled Depreciation75.8 K72.1 K16.3 K
Slightly volatile

Syra Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities2.3 M2.4 M921.5 K
Slightly volatile
End Period Cash Flow2.9 M2.8 M695.4 K
Slightly volatile
Begin Period Cash FlowM3.8 M656 K
Slightly volatile
Depreciation75.8 K72.1 K16.3 K
Slightly volatile
Other Non Cash Items185.8 K144.8 K91.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.410.4311.246
Slightly volatile
Days Sales Outstanding34.0135.867.2477
Slightly volatile
Average Payables402.4 K324.7 K429.4 K
Slightly volatile
Stock Based Compensation To Revenue0.00370.00670.0018
Slightly volatile
Capex To Depreciation0.190.221.978
Slightly volatile
EV To Sales0.140.1511.2983
Slightly volatile
Inventory Turnover77.2186.8694.8066
Slightly volatile
Days Of Inventory On Hand3.023.43.7147
Slightly volatile
Payables Turnover58.8256.0217.0533
Slightly volatile
Sales General And Administrative To Revenue0.430.540.3757
Slightly volatile
Average Inventory18.9 K21.2 K23.2 K
Slightly volatile
Research And Ddevelopement To Revenue0.04670.0660.0468
Slightly volatile
Capex To Revenue0.00150.00160.0048
Very volatile
Cash Per Share0.160.30.0872
Slightly volatile
Days Payables Outstanding6.416.7438.6598
Slightly volatile
Income Quality0.850.919.2475
Slightly volatile
Current Ratio5.164.921.5982
Slightly volatile
Receivables Turnover11.0810.556.0091
Slightly volatile
Capex Per Share0.00170.00180.0023
Slightly volatile
Average Receivables592.1 K1.1 M398.1 K
Slightly volatile
Revenue Per Share0.680.990.4224
Slightly volatile
Interest Debt Per Share0.05410.05790.0268
Slightly volatile
Debt To Assets0.130.140.5006
Slightly volatile
Operating Cycle34.0135.867.4701
Slightly volatile
Days Of Payables Outstanding6.416.7438.6598
Slightly volatile
Ebt Per Ebit1.111.151.0267
Slightly volatile
Long Term Debt To Capitalization0.04890.0550.06
Slightly volatile
Quick Ratio5.164.921.5964
Slightly volatile
Cash Ratio3.693.511.1492
Slightly volatile
Cash Conversion Cycle39.8929.0629.5333
Slightly volatile
Days Of Inventory Outstanding3.023.43.7147
Slightly volatile
Days Of Sales Outstanding34.0135.867.2477
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.151.0705
Very volatile
Fixed Asset Turnover18.2722.0713.6423
Slightly volatile
Debt Ratio0.130.140.5006
Slightly volatile
Price Sales Ratio0.410.4311.246
Slightly volatile
Asset Turnover2.292.492.4709
Slightly volatile
Gross Profit Margin0.260.240.2832
Slightly volatile

Syra Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.4 M3.4 M4.7 M
Slightly volatile
Enterprise Value1.6 M1.2 M1.8 M
Slightly volatile

Syra Fundamental Market Drivers

Syra Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Syra Health Financial Statements

Syra Health stakeholders use historical fundamental indicators, such as Syra Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Syra Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Syra Health's assets and liabilities are reflected in the revenues and expenses on Syra Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Syra Health Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.9 K13.3 K
Total Revenue9.2 M5.6 M
Cost Of Revenue7.3 M4.4 M
Sales General And Administrative To Revenue 0.54  0.43 
Research And Ddevelopement To Revenue 0.07  0.05 
Revenue Per Share 0.99  0.68 
Ebit Per Revenue(0.54)(0.57)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Syra Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syra Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syra Health Corp Stock:
Check out the analysis of Syra Health Correlation against competitors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syra Health. If investors know Syra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Revenue Per Share
0.662
Quarterly Revenue Growth
(0.25)
Return On Assets
(0.21)
Return On Equity
(0.46)
The market value of Syra Health Corp is measured differently than its book value, which is the value of Syra that is recorded on the company's balance sheet. Investors also form their own opinion of Syra Health's value that differs from its market value or its book value, called intrinsic value, which is Syra Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syra Health's market value can be influenced by many factors that don't directly affect Syra Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Syra Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Syra Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syra Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.